• Danazol Assays: Reproducible Endocrine Models

  2026-08-26

  A scenario-driven guide to using Danazol SKU C3644 in cell viability, proliferation, cytotoxicity, and endocrine signaling workflows. It covers solvent compatibility, protocol design, interpretation of pathway effects, and practical vendor-selection criteria supported by product data and recent rat-model evidence.

• MG-132 (Z-LLL-al) Proteostasis Workflow

  2026-08-26

  MG-132 (Z-LLL-al) provides a practical way to perturb proteasome-dependent protein turnover while tracking apoptosis, redox stress, cell-cycle changes, and receptor quality control. This workflow connects established cancer research applications with a carefully controlled autophagy study design for disease-associated GluN2B variants.

• Aligned Silk Fibroin–Ce6 Films for Infected Wounds

  2026-08-25

  The reference study integrates aligned electrospun silk fibroin fibers with covalently associated Chlorin e6 to create an anisotropic wound scaffold that combines directional cell guidance with near-infrared photodynamic antibacterial activity. In an S. aureus wound model, the composite reduced bacterial infection rapidly and supported later-stage M2 macrophage polarization, illustrating how material architecture and immune regulation can be combined in wound-care design.

• EHEC Delays Danazol-Induced Precocious Puberty

  2026-08-25

  A 2025 rat study evaluated an Eclipta prostrata–Hordeum vulgare extract complex (EHEC) in Danazol- and high-fat diet-induced models of precocious puberty. EHEC delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without changing body weight, supporting further investigation of botanical modulation of the hypothalamic–pituitary–gonadal axis.

• Dovitinib as a Perturbation Tool in Prostate Cancer

  2026-08-24

  Dovitinib (TKI-258) can serve as a pharmacologic perturbation tool for dissecting RTK signaling alongside the circRHOBTB3–NONO–MAOA axis in prostate cancer models. This article translates a recent mechanistic study into a practical, pathway-resolved assay strategy rather than another general drug overview.

• MDM1, p53, and Chemoradiotherapy Sensitivity in CRC

  2026-08-24

  This study identifies MDM1 as a functional determinant of colorectal cancer sensitivity to chemoradiotherapy, linking MDM1 overexpression to TP53 transcription, apoptosis, and improved treatment response. Its findings support MDM1 expression as a candidate predictive biomarker and clarify how YBX1-dependent regulation of the TP53 promoter may influence therapeutic resistance.

• Eclipta–Hordeum Extract Delays Precocious Puberty

  2026-08-23

  Kim et al. evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty triggered by Danazol or a high-fat diet. The complex delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without altering body weight, supporting further investigation of botanical modulation of the hypothalamic–pituitary–gonadal axis.

• Brefeldin A for Reliable Cell Assays

  2026-08-22

  Learn how Brefeldin A (SKU B1400) can improve the design and interpretation of viability, proliferation, trafficking, and apoptosis experiments. This scenario-based guide connects practical dosing, solvent control, ER-stress biology, and vendor-selection criteria to evidence-linked laboratory workflows.

• Sulfo-NHS-SS-Biotin for Cleavable Protein Labeling

  2026-08-22

  Sulfo-NHS-SS-Biotin combines water-compatible amine reactivity with a reducible disulfide spacer, enabling cell-surface capture, affinity purification, and controlled label removal. Its workflow is especially useful for separating transporter surface abundance from intracellular retention in mechanistic membrane-protein studies.

• Tin Mesoporphyrin IX: From HO Biology to Translation

  2026-08-21

  A translational framework for using Tin Mesoporphyrin IX (chloride) to test heme oxygenase biology across metabolic, inflammatory, and antiviral research while separating direct enzyme inhibition from indirect HO-1 and ROS effects.

• Danazol Workflows for Steroidogenesis Research

  2026-08-20

  Danazol and Danocrine provide a controlled way to probe steroidogenesis, androgen receptor signaling, and hypothalamic–pituitary–gonadal axis responses. This workflow-focused guide connects Leydig-cell assays with danazol-induced precocious-puberty models while emphasizing solvent control, endpoint selection, and reproducibility.

• 6-Thioguanine Blocks EV71 via BIRC3 Autophagy

  2026-08-20

  The 2025 BMC Microbiology study identifies 6-thioguanine as an in vitro inhibitor of EV71 replication and links its activity to reduced BIRC3-mediated complete autophagy. Its strong cell-based selectivity supports further antiviral investigation, while the single-cell-model design means that efficacy and dosing cannot yet be extrapolated to patients.

• MK-8745: Aurora A Inhibitor Workflow Guide

  2026-08-19

  MK-8745 combines high biochemical potency with a selective Aurora A mechanism for connecting mitotic disruption to apoptosis in cancer models. This guide translates retinoblastoma evidence into practical cell-based, tissue-derived, and xenograft assay workflows, with dosing, controls, and troubleshooting recommendations.

• C8-HSL and Lung Cancer Progression via PI3K/AKT/ERK

  2026-08-19

  The reference study identifies the bacterial quorum-sensing molecule C8-HSL as a potential host–microbe factor that enhances lung cancer cell proliferation, migration, and invasion through PI3K/AKT/ERK signaling. Its integrated in vitro and in vivo design connects a microbial communication signal with tumor-associated phenotypes while also highlighting important limitations for clinical translation.

• ML133 HCl: A Practical Kir2.1 Workflow

  2026-08-18

  ML133 HCl is a selective potassium channel inhibitor for connecting Kir2.1 activity with membrane physiology, PASMC remodeling, and migration phenotypes. This guide translates published PASMC experiments into practical preparation, dosing, assay-design, and troubleshooting decisions.

8571 records 1/572 page Next 12345 下5页 Last page